Business Context and Reporting Period
This Form 8-K Current Report was filed by Barnes & Noble Education, Inc. on February 27, 2024. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the company's continued listing status.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance and listing compliance matters.
Material Changes
- Share Price Deficiency: The NYSE notified the Company that the average closing price of its Common Stock (Symbol: BNED) fell below $1.00 per share for 30 consecutive trading days.
- Listing Status: The stock will continue to trade on the NYSE but will carry a ".BC" designation to indicate non-compliance with continued listing requirements.
- Compliance Period: The Company has a six-month cure period from the date of the notice to regain compliance.
Outlook, Management Commentary, and Risks
Management Action: The Company intends to actively monitor the closing price of its Common Stock and evaluate available options to cure the deficiency.
Compliance Requirements: To regain compliance, the Common Stock must achieve a closing price of at least $1.00 per share and an average closing price of at least $1.00 per share over a 30-trading-day period ending on the last trading day of any calendar month during the cure period.
Risks: If the Company fails to regain compliance within the six-month period, the NYSE will initiate procedures to suspend and delist the Common Stock.
Investor Verification Checklist
- Verify the current trading price and 30-day average of BNED stock to assess progress toward the $1.00 threshold.
- Monitor for future press releases or filings regarding potential capital actions (e.g., reverse stock splits) to address the price deficiency.
- Review the attached press release (Exhibit 99.1) for any additional management commentary on the situation.
- Confirm the specific deadline dates for the six-month cure period to track compliance milestones.